Beta-Lactamase DataBase (BLDB): Structure and Function
Beta-Lactamase DataBase
Beta-Lactamase DataBase - Structure and Function Home Enzymes Structures Mutants Kinetics BLAST
Beta-Lactamase DataBase

Sequence alignment for the OXA-229-like beta-lactamase family

OXA-228
........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270......
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERVTEIPLLFNQAQTQAVFVTYDGIHLKSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAEAMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFAYQLAMKQLPFDSNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKVTAFALNMNMQAGNDPAERKQLTLSILDKLGLFFYLR
OXA-229...................................E.......D................................................................................................................................................................................................................D..T.................... 98.55 %
OXA-230...................................E.......................................................G........Q..........................................................................................R.................................................................................... 98.55 %
OXA-257.........Y.........................E...........................................................................................................................................................R.......................................................K....D.L..................... 97.83 %
OXA-300...................................E.......................................................G........Q......................................K...................................................R.............S..............................................D....................... 97.46 %
OXA-301...................................E................................................................................................................................................................................................................................................ 99.64 %
OXA-355...................................E...........................................................................................................................................................R............................................................D....................... 98.91 %
OXA-356...................................E..............................................................I............................................................................................R............................................................D....................... 98.55 %
OXA-418...................................E...........................................................................................................................................................R.......N......................K.............................D....................... 98.19 %
OXA-895...................................E.......................................................G........Q.......................................................................................................................................................D....................... 98.55 %
OXA-952...................................E.............................................................................................................................................K.............R.......................................................K....D....................... 98.19 %
OXA-953...................................E....................................Q......................................................................................................................R............................................................D....................... 98.55 %
OXA-983...................................E...........................................................................................................................................................R............................................D...............D....................... 98.55 %
OXA-1001...................................E...........................................................................................................................................................R.......................................................K....D....................... 98.55 %
OXA-1052...................................E...........................................................................................................................................................R.......................................................S....D....................... 98.55 %
OXA-1144...................................E.............................................................................................................................................K.............R.......................................................K...ED....................... 97.83 %
OXA-1190...................................E..............................................................I..............................................................................K.............R............................................D...............D....................... 97.83 %
OXA-1191.........Y.......................G.E..............................................................I.......................................F....................................................R.......................................................K....D....................... 97.10 %
OXA-1192...................................E............................................................................................................................................................S...........................................................D..T.................... 98.55 %
OXA-1193...................................E...........................................................................................................................................................R.............S.........................................K....D....................... 98.19 %
OXA-1194...................................EI............................................................................................................................................................................................................................................... 99.28 %
OXA-1195...................................E...........................................................................................................................................................R.............S.A...........................S...........K....D....................... 97.46 %
OXA-1196...................................E.......................................................G........Q......................................K........A..................................................................................................K....D....................... 97.46 %
OXA-1197..........I........................E.......................................................G........Q..........................................................................................R.......................................................K....D....................... 97.46 %
OXA-1375..............T....................E................................................................................................................................................................................................................................................ 99.28 %
D-OXA-229-like phylogenetic tree

Last updated: April 06, 2026.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database was funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu

Live statistics (since March 29th, 2025)